ATOMMAP
Live / Applied — Second extension granted (statement of use) (as of 05 Nov 2025)
What this means for you
Not registered yet, but its 19 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98367132
- Mark type
- Stylized text
- Filed
- 19 Jan 2024
- Published for opposition
- 17 Sept 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for prevention and treatment of auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, rare, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, and sensory diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of chronic diseases, conditions and functional disorders namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, rare, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases, conditions, and disorders; Pharmaceutical preparations for diagnosis, prevention and treatment of diseases by gene therapy, namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases
Owner
- Atommap Corporation, Washington, DC, US
- Atommap Corporation, Washington, DC, US
Prosecution history
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 2 GRANTED
- 05 Nov 2025 — SOU EXTENSION 2 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2025 — SOU EXTENSION 1 GRANTED
- 08 May 2025 — SOU EXTENSION 1 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2024 — ASSIGNED TO EXAMINER
- 20 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED